PPARG and peritonitis: Moreover, the administration of rhEPO significantly enhanced levels of macrophage PPARγ (Figures 4D, E and S4C, D) and myeloid EPOR deficiency strongly reduced levels of macrophage PPARγ during E. coli-induced peritonitis (Figures 4E and S4D).